Katherine Fuh

Dr. Katherine Fuh is a gynecologic oncologist who cares for patients with cancers of the female reproductive system, including advanced ovarian and uterine cancers.

Fuh earned her medical degree and a master's degree in physiology at the Georgetown University School of Medicine. She completed a residency in obstetrics and gynecology at Stanford University School of Medicine, where she also completed a doctorate in cancer biology. She completed a fellowship in gynecologic oncology through a joint program of Stanford and UCSF, as well as a rotation in gynecologic oncology at the Memorial Sloan Kettering Cancer Center.

Fuh's research focuses on developing better treatments for patients with gynecologic cancers. She serves on national committees for clinical trials (studies of promising therapies using human volunteers) and translational research (the process of applying study findings to patient care), including as the translational co-chair for the Uterine Corpus Cancer Subcommittee of NRG Oncology. A leader of national and international clinical trials, she is currently the international lead for a phase III study of a treatment for ovarian, fallopian tube and peritoneal cancer.

Fuh is a member of the Society of Gynecologic Oncology, American Society of Clinical Oncology, American Association for Cancer Research and Society for Reproductive Investigation. She is also a member of the ovarian cancer subcommittee of NRG Oncology and gynecologic research groups sponsored by the National Institutes of Health, including the National Cancer Institute Developmental Therapeutics Clinic.